Equities

Diamond Biofund Inc

6901:TAI

Diamond Biofund Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (TWD)39.60
  • Today's Change0.40 / 1.02%
  • Shares traded580.76k
  • 1 Year change-12.00%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments9,64710,73810,087
Total Receivables, Net1.121.871.69
Total Inventory------
Prepaid expenses------
Other current assets, total7.510.800.08
Total current assets9,65610,74110,089
Property, plant & equipment, net1255.7044
Goodwill, net------
Intangibles, net0.140.28--
Long term investments3,235445487
Note receivable - long term------
Other long term assets262.592.59
Total assets13,04211,19410,623
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases153.678.73
Other current liabilities, total51140189
Total current liabilities66144198
Total long term debt114033
Total debt1293.6742
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities180144231
SHAREHOLDERS EQUITY
Common stock8,4996,3505,000
Additional paid-in capital3,530131.16
Retained earnings (accumulated deficit)8334,6885,391
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity12,86211,05010,392
Total liabilities & shareholders' equity13,04211,19410,623
Total common shares outstanding850749749
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.